Suppr超能文献

2019年冠状病毒病时代的超声心动图:诊断与预后的单一工具

Echocardiography in Coronavirus Disease 2019 Era: A Single Tool for Diagnosis and Prognosis.

作者信息

Aragona Caterina Oriana, Bagnato Gianluca, Tomeo Simona, Rosa Daniela La, Chiappalone Marianna, Tringali Maria Concetta, Singh Emanuele Balwinder, Versace Antonio Giovanni

机构信息

Department of Emergency, Unit of Emergency Mecicine, AOU Policlinico "G.Martino", University of Messina, Messina, Italy.

出版信息

J Cardiovasc Echogr. 2023 Jan-Mar;33(1):10-16. doi: 10.4103/jcecho.jcecho_11_23. Epub 2023 May 29.

Abstract

Coronavirus disease 2019 (COVID-19) is characterized by multi-organ involvement, including respiratory and cardiac events. Echocardiography is widely considered the first-choice tool for the evaluation of cardiac structures and function because of its reproducibility, feasibility, easy to use at bedside, and for good cost-effectiveness. The aim of our literature review is to define the utility of echocardiography in the prediction of prognosis and mortality in COVID-19 patients with mild to critical respiratory illness, with or without known cardiovascular disease. Moreover, we focused our attention on classical echocardiographic parameters and the use of speckle tracking to predict the evolution of respiratory involvement. Finally, we tried to explore the possible relationship between pulmonary disease and cardiac manifestations.

摘要

2019冠状病毒病(COVID-19)的特征是多器官受累,包括呼吸和心脏方面的症状。由于超声心动图具有可重复性、可行性、便于床旁操作以及良好的成本效益,因此被广泛认为是评估心脏结构和功能的首选工具。我们进行文献综述的目的是确定超声心动图在预测患有轻至重症呼吸道疾病、有无已知心血管疾病的COVID-19患者的预后和死亡率方面的效用。此外,我们重点关注经典超声心动图参数以及使用斑点追踪技术来预测呼吸受累的进展情况。最后,我们试图探究肺部疾病与心脏表现之间可能存在的关系。

相似文献

引用本文的文献

1
Constrictive Pericarditis: An Update on Noninvasive Multimodal Diagnosis.缩窄性心包炎:无创多模态诊断的最新进展
J Cardiovasc Echogr. 2023 Oct-Dec;33(4):161-170. doi: 10.4103/jcecho.jcecho_61_23. Epub 2024 Feb 26.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验